Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. 2000

V G Arzumanyan, and O O Magarshak, and B F Semenov
I. I. Mechnikov Institute of Vaccines and Sera, Russian Academy of Medical Sciences, Moscow.

Yeast microflora was studied in the skin of 91 patients with atopic dermatitis, in bronchial secretion of 13 patients with bronchial asthma and 8 patients with allergic bronchopulmonary mycosis. Forty-eight isolates were obtained. Alypophilic yeast fungi isolated from the skin were presented mainly by genera Candida spp. (48%) and Rhodotorula spp. (29%), while the cultures isolated from bronchial secretion mainly by Candida albicans. The sensitivity of yeast cultures to the antifungal drugs diflucan, clotrimazole, nizoral, orungal, exoderil, levorin, pymafuzin, and nitrofungin was determined. The most efficient drugs were diflucan, clotrimazole, nizoral, and orungal. More than half isolates were sensitive only to the high concentrations of levorin (48%), pymafuzin (75%), and nitrofungin (82%); 64% isolates were insensitive even to high concentrations of exoderil. Preliminary in vitro selection of the antifungal drugs is required for efficient elimination of the yeasts.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V G Arzumanyan, and O O Magarshak, and B F Semenov
January 1970, Transactions of the ophthalmological societies of the United Kingdom,
V G Arzumanyan, and O O Magarshak, and B F Semenov
April 1989, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
V G Arzumanyan, and O O Magarshak, and B F Semenov
April 2001, Bulletin of experimental biology and medicine,
V G Arzumanyan, and O O Magarshak, and B F Semenov
January 1999, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
V G Arzumanyan, and O O Magarshak, and B F Semenov
September 2018, Journal of fungi (Basel, Switzerland),
V G Arzumanyan, and O O Magarshak, and B F Semenov
March 2016, Arerugi = [Allergy],
V G Arzumanyan, and O O Magarshak, and B F Semenov
January 1985, Medycyna doswiadczalna i mikrobiologia,
V G Arzumanyan, and O O Magarshak, and B F Semenov
October 2009, European journal of medicinal chemistry,
V G Arzumanyan, and O O Magarshak, and B F Semenov
January 1966, Przeglad epidemiologiczny,
Copied contents to your clipboard!